Physician profile
James W Stands
NPI 1710957766
$1,541.18
in general payments reported to CMS, 2019-2025
28 companies · $99.63 in 2025
The $99.63 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $105 · 2021: $14.13 · 2022: $375 · 2023: $173 · 2024: $102 · 2025: $99.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $373.86 | 2019-2024 | Vraylar, Liletta |
| Duchesnay USA Incorporated | $171.66 | 2019 | |
| Pfizer INC. | $103.12 | 2019-2023 | |
| Novo Nordisk INC | $85.76 | 2019-2024 | Wegovy |
| Astellas Pharma US INC | $85.43 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $84.04 | 2022-2025 | Slynd |
| Daiichi Sankyo INC. | $62.82 | 2019-2025 | Injectafer |
| Lupin INC. | $57.55 | 2019-2020 | |
| Myovant Sciences INC. | $56.63 | 2022 | |
| Amag Pharmaceuticals, INC. | $50.92 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.94 | 2022 | |
| Ethicon US, LLC | $37.89 | 2019 | |
| Therapeuticsmd, INC. | $37.52 | 2019 | |
| Avion Pharmaceuticals | $34.07 | 2022 | |
| Evofem Biosciences, INC. | $30.77 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $27.83 | 2023 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $26.32 | 2019-2023 | Paragard T 380a |
| Allergan, INC. | $23.74 | 2019 | |
| Supernus Pharmaceuticals, INC. | $21.40 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $21.40 | 2025 | Zurzuvae |
| Vertical Pharmaceuticals, LLC | $18.96 | 2019 | |
| Exact Sciences Corporation | $14.57 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $14.31 | 2019 | |
| Hologic Sales and Service, LLC | $14.13 | 2021 | |
| Mission Pharmacal Company | $12.07 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.75 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $10.90 | 2019 | |
| Coloplast Corp | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.